mr KENNETH RASKE

Support Medicare GME expansion proposals: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act, additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act. Discuss rural reclassification for Medicare wage index and Medicare GME purposes. Support legislative proposals to permanently extend PHE telehealth flexibilities and further extend Medicare Acute Hospital Care at Home Waiver. Oppose Medicare site-neutral payment policies. Oppose unique national provider identifier (NPI) requirement for hospital outpatient departments and discuss implementation - H.R. 7148-Sec. 6225. Support Medicare Advantage reforms - Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816), MA Prompt Pay Act (H.R. 5454/S.2879). Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges, make permanent three-day hospital stay waiver, extend COVID-19 regulatory flexibilities, address Medicare Advantage issues, support health care workforce investments. Oppose Medicaid program and financing changes in H.R. 1: work requirements as a condition of coverage, changes to state-directed payments, reductions to Federal matching funds, reductions to the safe harbor threshold for provider taxes, sunset of broad-based and uniform provider tax waivers, rescission of Medicaid Eligibility rule and Medicaid/CHIP Access rule, reductions to retroactive coverage. Discuss Medicaid Section 1115 waiver. Discuss Calendar Year 2027 Medicare Outpatient Prospective Payment Rule; oppose site-neutral proposals and proposed reductions to 340B reimbursement. Oppose CMS pricing methodology for proton therapy centers. Support creation of new reimbursement pathway for mobile stroke units.

Oppose H.R. 1 limitations on premium tax credit eligibility. Support Restoring Essential Plan Coverage Act, H.R. 10692/S.5619, repealing H.R. premium tax credit eligibility restrictions and creating permanent option for expanded basic health plan. Support permanently extending Affordable Care Act enhanced premium tax credits. Support 340B Drug Pricing Program and discuss certain changes: oppose 340B ACCESS Act, SECURE 340B Act, HRSA Rebate Model Pilot Program, support enforcement action against manufacturer claims data policies. Support recommendations to address workforce shortages for nursing and ancillary health care workforce: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training sites, and immigration reforms that expedite entry for foreign health care workers. Support SAVE Healthcare Workers Act (H.R. 3178/S. 1600). Discuss New York State transition from Affordable Care Act Section 1332 State Innovation Waiver to Section 1331 Basic Health Plan. Discuss legislative proposals to regulate the use of artificial intelligence in health care settings. Discuss non-profit tax-exempt status of hospitals and examples of community benefit for IRS purposes (H.R. 9504, Tax Exempt Hospital Transparency Act). Discuss price transparency regulations and legislative proposals: Lower Costs, More Transparency Act; Patients Deserve Price Tags Act; Prices on the Wall Act; Transparency in Billing Act, Health Care Price Certainty for All Americans Act. Support commercial insurance reforms. Discuss antitrust exemption for National Resident Matching Program. Discuss organ donation policies.

Discuss with Congressional staff and HHS staff support for Medicare GME expansion and changes to GME program: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act; additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act; concerns on Rural Physician Workforce Preservation Act; Senate Finance Committee proposals to increase GME slots. Discuss with Congressional staff opposition to Medicaid proposals in H.R.1: work requirements as a condition of coverage, changes to state-directed payments, reductions to Federal matching funds, reductions to the safe harbor threshold for provider taxes, sunsetting uniform tax waivers, rescission of Medicaid Eligibility rule and Medicaid/CHIP Access rule, reductions to retroactive coverage, reduction of reasonable opportunity window. Discuss technical amendment to CAA, 2021, Sec. 131 pertaining to Medicare GME with Congressional staff. Discuss with Congressional staff distribution methodology for Medicare GME slots created in the CAA, 2021. Discuss expiring COVID-19 Public Health Emergency (PHE) Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver. Support extension of Medicare Dependent Hospital and Low-Volume Adjustment programs. Discuss opposition to Medicare site-neutral payment policies with Congressional staff. Oppose changes to NPIs for hospital outpatient departments (118th Congress: H.R. 7623, H.R. 4509, H.R. 7623 as amended, H.R. 4822). Discuss FY 2024 IPPS comments with Congressional, HHS staff: to increase payment update to hospitals, Transforming Episodic Accountability Model, AHEAD Model, and CAA, 2023 Sec 4122 GME slot distribution methodology. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Support certain changes to Medicaid DSH payments: support two-year elimination of Medicaid DSH cut scheduled for January 1, 2025; support Save Our Safety Net Hospitals Act to restore pre-CAA, 2021 DSH cap calculation methodology and include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver with Congressional staff and HHS. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver. Discuss Medicaid IMD exclusion policies with Congressional staff. Support legislation to increase Medicaid payment rates for labor and delivery services for certain hospitals (118th Congress: S.5236). Oppose CMS final rule to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities (89 FR 40876) and support legislative efforts to repeal rule. Support Medicare Advantage prior authorization reforms - Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816). Discuss wage index issues with Congressional staff: H.R. 8561 to address MA local area growth under projection, FY 2025 IPPS/LTCH interim final rule, indirect medical education (IME) payments to hospitals. Meet with CMS leadership to discuss Medicare and Medicaid issues: prior authorization and MA insurance denials, concerns on mandatory participation for AHEAD and TEAM models, Medicare support for health care workforce; support for telehealth flexibilities and Acute Hospital Care at Home waiver extension. Discuss Medicare wage index issues with CMS. Discuss Medicaid Section 1332 waiver with Congressional staff. Urge delayed enforcement of CMS final rule prohibiting nurses from performing glucose tests using high-complexity devices in point-of-care situations.

Discuss Medicare GME funding in CAA, 2021 and CAA, 2023 with Congressional staff and HHS staff. Discuss disaster relief funding and health and hospital provisions in CAA, 2024 (H.R. 4366); Further Consolidated Appropriations Act, 2024 (H.R. 2882), Further Continuing Appropriations and Disaster Relief Supplemental Act, 2025 (H.R. 10445); American Relief Act, 2025; Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968). Support health extenders in H.R. 1968: extend COVID-19 Medicare-covered telehealth flexibilities, Acute Hospital Care at Home waiver, Medicaid DSH cut delay; discuss with Congressional staff and HHS staff.

Discuss with Congressional staff and HHS staff support for Medicare GME expansion and changes to GME program: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act (H.R. 7050); additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855); concerns on Rural Physician Workforce Preservation Act; Senate Finance Committee proposals to increase GME slots. Discuss technical amendment to CAA, 2021, Sec. 131 pertaining to Medicare GME with Congressional staff. Discuss with Congressional staff distribution methodology for Medicare GME slots created in the CAA, 2021. Discuss expiring COVID-19 Public Health Emergency (PHE) Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver. Support extension of Medicare Dependent Hospital and Low-Volume Adjustment programs. Support proposals to reduce payment cut in CY 2025 Physician Fee Schedule final rule. Discuss opposition to Medicare site-neutral payment policies with Congressional staff. Oppose changes to NPIs for hospital outpatient departments (H.R. 7623, H.R. 4509, H.R. 7623 as amended, H.R. 4822). Comment on FY 2024 IPPS rule to increase payment update to hospitals, Transforming Episodic Accountability Model, AHEAD Model, and CAA, 2023 Sec 4122 GME slot distribution methodology, and discuss comments with Congressional staff and CMS staff. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss with Congressional staff opposition to proposals to reduce the Medicaid program: work requirements as a condition of coverage, changes to state-directed payments, block grants, per capita caps, reductions to federal matching funds, reductions to the safe harbor threshold for provider taxes, rescission of Medicaid Eligibility rule and Medicaid/CHIP Access rule. Support certain changes to Medicaid DSH payments: support two-year elimination of Medicaid DSH cut scheduled for January 1, 2025; support Save Our Safety Net Hospitals Act (H.R. 9351) to restore pre-CAA, 2021 DSH cap calculation methodology and include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver. Discuss Medicaid IMD exclusion policies with Congressional staff. Support legislation to increase Medicaid payment rates for labor and delivery services for certain hospitals (118th Congress: S.5236). Discuss with Congressional staff support for CMS approval of Medicaid managed care organization tax proposed in New York State budget. Oppose CMS final rule to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities (89 FR 40876) and support legislative efforts to repeal rule. Support Medicare Advantage prior authorization reforms - Improving Seniors Timely Access to Care Act (118th Congress: S. 4532/H.R. 8702). Discuss wage index issues with Congressional staff: H.R. 8561 to address MA local area growth under projection, FY 2025 IPPS/LTCH interim final rule, indirect medical education (IME) payments to hospitals. Meet with CMS leadership to discuss Medicare and Medicaid issues: prior authorization and MA insurance denials, concerns on mandatory participation for AHEAD and TEAM models, Medicare support for health care workforce; support for telehealth flexibilities and Acute Hospital Care at Home waiver extension. Discuss Medicare wage index issues with CMS. Discuss Medicare Part B payment for unlicensed physicians with CMS. Support New York State Essential Plan (Medicaid Section 1332 Waiver) and oppose proposals to reduce coverage. Urge delayed enforcement of CMS final rule prohibiting nurses from performing glucose tests using high-complexity devices in point-of-care situations.

Discuss Medicare GME funding in CAA, 2021 and CAA, 2023 with Congressional staff and HHS staff. Discuss Medicare Nursing and Allied Health Education Payment Policies in CAA, 2023 Section 4143 Implementation with House Ways and Means staff. Discuss disaster relief funding and health and hospital provisions in CAA, 2024 (H.R. 4366); Further Consolidated Appropriations Act, 2024 (H.R. 2882), Further Continuing Appropriations and Disaster Relief Supplemental Act, 2025 (H.R. 10445); American Relief Act, 2025; Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968). Meeting with House Ways and Means Committee staff to discuss safety net hospital funding issues and payments for safety net hospitals. Meeting with CMS Regional Administration to discuss safety net funding issues. Support health extenders in H.R. 1968: extend COVID-19 Medicare-covered telehealth flexibilities, Acute Hospital Care at Home waiver, Medicaid DSH cut delay; discuss with Congressional staff and HHS staff. Discuss NIH funding relating to indirect costs for scientific research.

Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss opposition to Medicare site-neutral payment policies with Congressional staff. Educate Congressional staff on hospital price transparency federal rule (84 FR 65602). Oppose changes to NPIs for hospital outpatient departments (H.R. 7623, H.R. 4509, H.R. 7623 as amended, H.R. 4822). Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier (NPI) requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Discuss hospital and health provisions in CAA, 2024 (H.R. 4366) with HHS staff and Congressional staff: support public health extenders and elimination of Medicaid DSH cut. Discuss support for the 340B Drug Pricing Program with Congressional staff and discuss certain changes: oppose 340B ACCESS Act (H.R. 7635), comment on SUSTAIN 340B Act discussion draft, support PATIENTS Act (H.R. 7635); oppose back-end rebate proposals. Discuss legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff. Discuss with Congressional staff support for Medicare GME expansion and changes to GME program: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act (H.R. 7050); additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855); concerns on Rural Physician Workforce Preservation Act and opposition to modifications to ongoing slot distribution; Senate Finance Committee draft proposals to increase GME slots. Discuss with HHS staff and Congressional staff recommendations to address workforce shortages for nursing and ancillary health care workforce: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S.2768). Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME: S.665/H.R.4942, S.2719/H.R.6980, H.R. 4875. Discuss expiring COVID-19 Public Health Emergency Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver: H.R. 7623. Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards (S.5218). Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff. Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff. Support Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702). Discuss legislative proposals on consumer medical debt with Congressional staff. Outreach to HHS Assistant Secretary for Preparedness and Response urging certain regulatory flexibilities to alleviate IV fluid shortages.

Discuss Medicare and Medicaid issues with HHS staff. Discuss with Congressional staff and HHS staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act; additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855). Discussion with CMS on the interpretation of CAA, 2021, Sec. 131, and resetting of GME caps pertaining to Sec. 131. Discuss technical amendment to CAA, 2021, Sec. 131 pertaining to Medicare GME with Congressional staff. Discuss with Congressional staff distribution methodology for Medicare GME slots created in the CAA, 2021. Discuss expiring COVID-19 Public Health Emergency (PHE) Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver (H.R. 7623). Discuss legislation to provide financial support for safety net hospitals. Discuss opposition to Medicare site-neutral payment policies with Congressional staff. Support certain changes to Medicaid DSH: support two year elimination of Medicaid DSH cut scheduled for January 1, 2025; support Save Our Safety Net Hospitals Act (H.R. 9351) to restore pre-CAA, 2021 DSH cap calculation methodology and include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver. Discuss Medicaid IMD exclusion policies with Congressional staff. Support legislation to increase Medicaid payment rates for labor and delivery services for certain hospitals (S.5236). Discuss with Congressional staff support for CMS approval of Medicaid managed care organization tax proposed in New York State budget. Discuss comments on FY 2024 IPPS proposed rule to increase payment update to hospitals, Transforming Episodic Accountability Model, AHEAD Model, and CAA, 2023 Sec 4122 GME slot proposed distribution methodology and discuss comments with Congressional staff and CMS staff. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Meet with CMS Regional Administrator to discuss the behavioral health care workforce. Meet with CMS to discuss hospital price transparency regulations. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Oppose CMS final rule to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities (89 FR 40876) and support legislative efforts to repeal rule. Meet with CMS staff to discuss behavioral health coverage for commercial insurers. Discussion with HHS Health Insurance Administrator and CMS Hospital Quality, Safety, and Oversight Group on CMS Interpretive Guidance on Informed Consent. Support Medicare Advantage prior authorization reforms. Meet with CMS staff and CMS Regional Administrator to discuss Medicare Advantage (MA) plans and MA utilization management practices. Discuss wage index issues with Congressional staff: H.R. 8561 to address MA local area growth under projection, FY 2025 IPPS/LTCH interim final rule, indirect medical education (IME) payments to hospitals. Meet with CMS Innovation Center to discuss CMMI models of care. Meet with CMS leadership to discuss Medicare and Medicaid issues: prior authorization and MA insurance denials, concerns on mandatory participation for AHEAD and TEAM models, Medicare support for health care workforce; support for telehealth flexibilities and Acute Hospital Care at Home waiver extension. Meet with CMS/Acute Care regarding the definition of new residency programs.

Discuss Medicare GME funding in CAA, 2021 and CAA, 2023 with Congressional staff and HHS staff. Discuss Medicare Nursing and Allied Health Education Payment Policies in CAA, 2023 Section 4143 Implementation with House Ways and Means staff. Meeting with House Ways and Means Committee staff to discuss safety net hospital funding issues and payments for safety net hospitals. Meeting with CMS Regional Administration to discuss safety net funding issues. Discuss health and hospital provisions in CAA, 2024 (H.R. 4366) and Further Consolidated Appropriations Act, 2024 (H.R. 2882). Support supplemental disaster funding for FEMA in Continuing Appropriations and Extension Act, 2025 (H.R. 9747).

Discuss Medicare and Medicaid issues with HHS staff. Meet with Congressional staff and discuss support for Medicare graduate medical education (GME) funding, including support for the Resident Physician Shortage Reduction Act, the Opioid Workforce Act, Substance Use Disorder Workforce Act, the Pathway to Practice program proposal, and the Presidents FY 2025 budget request. Discussion with CMS on the interpretation of CAA, 2021, Sec. 131, and resetting of GME caps pertaining to Sec. 131. Discuss technical amendment to CAA, 2021, Sec. 131 pertaining to Medicare GME with Congressional staff. Meet with Congressional staff to discuss distribution methodology for Medicare GME slots created in the CAA, 2021. Discuss telehealth issues with Congressional staff and support for the permanent extension of COVID-19 PHE telehealth flexibilities. Discuss Acute Hospital Care at Home waiver and support for extension. Discuss legislation to provide financial support for safety net hospitals. Discuss opposition to site-neutral payment policies with Congressional staff. Advocate for two-year elimination of Medicaid DSH cut. Support elimination of Medicaid DSH cut in CAA, 2024 (H.R. 4366). Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver. Discuss Medicaid IMD exclusion policies with Congressional staff. Discuss legislative proposals for Medicaid support for rural and safety net hospitals providing maternity, labor, and delivery services to vulnerable populations. Discuss with Congressional staff support for CMS approval of Medicaid managed care organization tax proposed in New York State budget. Comment on FY 2024 IPPS proposed rule to increase payment update to hospitals, Transforming Episodic Accountability Model, and CAA, 2023 Sec 4122 GME slot proposed distribution methodology and discuss comments with Congressional staff and CMS staff. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Discussion with congressional staff regarding Medicare Disproportionate Share Hospital (DSH) rulemaking. Discuss CMS requirement to report telehealth provider home addresses with HHS staff. Meet with CMS Regional Administrator to discuss the behavioral health care workforce. Meet with CMS to discuss hospital price transparency regulations. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Oppose CMS final rule to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities (89 FR 40876) and support legislative efforts to repeal rule. Meet with CMS staff to discuss behavioral health coverage for commercial insurers. Discussion with HHS Health Insurance Administrator and CMS Hospital Quality, Safety, and Oversight Group on CMS Interpretive Guidance on Informed Consent. Support Medicare Advantage prior authorization reforms. Meet with CMS staff and CMS Regional Administrator to discuss Medicare Advantage (MA) plans and MA utilization management practices. Discuss with Congressional staff H.R.8561, to amend title XVIII of the Social Security Act to address significant under projection of MA local area growth due to wage index reclassification. Meet with CMS Innovation Center to discuss CMMI models of care. Discuss Making Care Primary model with CMMI staff.

Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss support for the 340B Drug Pricing Program with Congressional staff and oppose certain changes. Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss opposition to site-neutral payment policies with Congressional staff. Discuss hospital and health care provisions included in the Consolidated Appropriations Act of 2023 with Congressional staff. Discuss the following legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities. Support additional extension of the Acute Hospital Care at Home waiver. Educate Congressional staff on hospital price transparency federal rule (84 FR 65602). Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff. Discuss with Congressional staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act; additional GME slots in CAA, 2021 and CAA, 2023. Discuss legislative recommendations from Senate HELP Committee RFI response letter on workforce shortages for nursing and ancillary health care workforce with Congressional staff: faculty recruitment and retention, additional financial support for supervision and precepting students, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Discuss Making Care Primary model with CMMI staff. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Discuss community benefit standard and tax-exempt status of non-profit hospitals with Congressional staff. Respond to Senate RFI on 340B Drug Pricing Program - SUSTAIN 340B Act discussion draft. Discuss opposition to FDA Proposed Rulemaking on Laboratory Developed Tests (88 FR 68006) with Congressional staff. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies for drug administration services, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments. Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff. Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff. Discuss Further Continuing Appropriations and Other Extensions Act, 2024 (H.R. 6363); Continuing Appropriations Act, 2024 and Other Extensions Act (H.R. 5860); and Extension of Continuing Appropriations and Other Matters Act, 2024 (H.R. 7463) with Congressional staff and express support for funding extensions for: Community Health Centers, Teaching Health Center Graduate Medical Education funding, National Health Service Corps; support delay of Medicaid DSH cut in H.R. 6363, H.R. 5860, and H.R. 7463. Support public health extenders and elimination of Medicaid DSH cut in Consolidated Appropriations Act, 2024 (H.R. 4366). Meet with CMS staff to discuss behavioral health coverage for commercial insurers. Discussion with CMS Regional Administrator and Regional Health Coordinator on opioid access, 340B final rule, and Medicare Advantage utilization management practices. Meet with Congressional staff to discuss technical amendment to Section 131 of the Consolidated Appropriations Act of 2021. Meet with Congressional staff to discuss proposals for financial relief for hospitals affected by the Change Healthcare cyberattack. Discuss federal legislative proposals for sepsis reporting with Congressional staff. Discuss Earned Income Tax Credit and opposition to ERTC proposal in the Tax Relief for American Families and Workers Act of 2024 with Congressional staff. Discuss military graduate medical education (GME) with Congressional staff. Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act to create legal penalties for individuals who assault or intimidate hospital employees. Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards. Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff.

Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss support for the 340B Drug Pricing Program with Congressional staff and oppose changes. Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss opposition to site-neutral payment policies with Congressional staff. Discuss FEMA reimbursement for Employee Support Costs and Hazard Pay with FEMA. Discuss FEMA reimbursement for Employee Support Costs and Hazard Pay with Congressional staff. Discuss hospital and health care provisions included in the Consolidated Appropriations Act of 2023 with Congressional staff. Discuss the following legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss nursing and ancillary health care staff shortages and support reforms: faculty recruitment and retention, additional financial support for supervision and precepting students, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities: removing Medicare geographic and originating site restrictions, expanding the list of practitioners eligible to furnish telehealth services, extending telehealth services for federally qualified health centers and rural health clinics, delaying in-person Medicare requirements related to behavioral health care, and allowing audio-only services. Support the permanent extension of the Acute Hospital Care at Home waiver. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss the Resident Physician Shortage Reduction Act with Congressional staff. Discuss the Pathway to Practice Act of 2021 with Congressional staff. Discuss commercial insurance issues and health care workforce shortages with Senate Health, Education, Labor, and Pensions (HELP) Committee. Discuss GME provisions in the Consolidated Appropriations Act of 2023 with HHS staff. Educate Congressional staff on hospital price transparency federal rule. Respond to Senate HELP Committee Request for Information (RFI) on workforce shortages and supply legislative recommendations. Discuss legislative recommendations from Senate HELP Committee RFI response letter on workforce shortages with Senate Finance Committee staff. Discuss Making Care Primary model with CMMI staff. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Discuss end of PHE billing with HHS Health Insurance Administrator. Discuss PATIENT Act (HR 3561) with Congressional staff, including: price transparency proposal, opposition to site-neutral policies for drug administration, opposition to attestation requirements for hospital billing, opposition to changes to Inpatient Only List, support for Medicare Advantage reporting requirements, opposition to changes to 340B program, support for Community Health Center and health care workforce reauthorizations. Discuss community benefit standard and tax-exempt status of non-profit hospitals with Congressional staff. Respond to Senate RFI on 340B Drug Pricing Program. Discuss 340B remedy proposed rule with Congressional staff. Discuss opposition to FDA Proposed Rulemaking on Laboratory Developed Tests with Congressional staff. Discuss HHS Climate Pledge and Inflation Reduction Act funding with HHS staff. Meet with Senate staff to discuss requests for health care workforce investments in FY 2024 Labor-HHS-Ed appropriations legislation. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies for drug administration services, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments. Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff. Discuss Continuing Appropriations Act, 2024 and Other Extensions Act (H.R. 5860) with Congressional staff and express support for funding extensions for: Community Health Centers, Teaching Health Center Graduate Medical Education funding, National Health Service Corps; support delay of Medicaid DSH cut. Discuss Further Continuing Appropriations and Other Extensions Act, 2024 (H.R. 6363) with Congressional staff and express support for funding extensions for: Community Health Centers, Teaching Health Center Graduate Medical Education funding, National Health Service Corps; support delay of Medicaid DSH cut. Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff.

Meet with Congressional staff and discuss support for Medicare graduate medical education funding, including support for the Resident Physician Shortage Reduction Act, the Opioid Workforce Act, Substance Use Disorder Workforce Act, the Pathway to Practice program proposal, and the Presidents FY 2024 budget request. Advocate for the inclusion of Medicare GME funding in FY 2024 federal budget. Meet with HHS Region II to discuss GME legislation - the Resident Physician Shortage Reduction Act. Discuss Medicare and Medicaid issues with HHS Assistant Secretary for Legislation. Support delay of Medicaid DSH cut and advocate for passage of legislation to delay Medicaid DSH Cut (H.R. 2665, Supporting Safety Net Hospitals Act). Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss telehealth issues with Congressional staff and support for the permanent extension of PHE telehealth flexibilities. Discuss Acute Hospital Care at Home waiver and support for its permanent extension. Discuss legislation to provide support for safety net hospitals. Discuss issues concerning DSH hospitals with the Executive Branch. Meet with CMS Innovation Center to discuss CMMI models of care. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss opposition of site-neutral payment policies with Congressional staff. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities: removing Medicare geographic and originating site restrictions, expanding the list of practitioners eligible to furnish telehealth services, extending telehealth services for federally qualified health centers and rural health clinics, delaying in-person Medicare requirements related to behavioral health care, and allowing audio-only services. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss Making Care Primary model with CMMI staff. Discuss Medicaid waiver application with CMS staff. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver application. Meet with CMS staff regarding Medicare managed care. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Express opposition to Medicaid work requirements in Limit, Save, Grow Act of 2023 to Congressional staff. Discuss Medicaid IMD exclusion policies with Congressional staff. Discuss with Congressional staff support for revisions to FY 2024 IPPS proposed rule to increase payment update to hospitals. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Discussion with congressional staff regarding Medicare Disproportionate Share Hospital (DSH) rulemaking.

Advocate for inclusion of Medicare GME funding in the Presidents FY 2024 budget request. Discuss Medicare GME funding in Consolidated Appropriations Act, 2023 with Congressional staff and HHS staff. Discuss Medicare Nursing and Allied Health Education Payment Policies in Consolidated Appropriations Act, 2023 Section 4143 Implementation with House Ways and Means staff. Meeting with House Ways and Means Committee staff to discuss safety net funding issues. Meeting with CMS Regional Administration to discuss safety net funding issues.

Meet with Congressional staff and discuss support for Medicare graduate medical education funding, including support for the Resident Physician Shortage Reduction Act, the Opioid Workforce Act, Substance Use Disorder Workforce Act, the Pathways to Practice program proposal, and the Presidents FY 2024 budget request. Advocate for the inclusion of Medicare GME funding in FY 2024 federal budget. Meet with HHS Region II to discuss GME legislation - the Resident Physician Shortage Reduction Act. Discuss Medicare and Medicaid issues with HHS Assistant Secretary for Legislation. Support delay of Medicaid DSH cuts. \ Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss telehealth issues with Congressional staff and support for the permanent extension of PHE telehealth flexibilities. Discuss Acute Hospital Care at Home waiver and support for its permanent extension. Discuss legislation to provide support for safety net hospitals. Discuss issues concerning DSH hospitals with the Executive Branch. Meet with CMS Innovation Center to discuss CMMI models of care. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss opposition of site-neutral payment policies with Congressional staff. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities: removing Medicare geographic and originating site restrictions, expanding the list of practitioners eligible to furnish telehealth services, extending telehealth services for federally qualified health centers and rural health clinics, delaying in-person Medicare requirements related to behavioral health care, and allowing audio-only services. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss Making Care Primary model with CMMI staff. Discuss Medicaid waiver application with CMS staff. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver application. Meet with CMS staff regarding Medicare managed care. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Express opposition to Medicaid work requirements in Limit, Save, Grow Act of 2023 to Congressional staff. Discuss Medicaid IMD exclusion policies with Congressional staff. Discuss with Congressional staff support for revisions to FY 2024 IPPS proposed rule to increase payment update to hospitals.

Meet with Congressional staff and discuss support for Medicare graduate medical education funding, including support for the Resident Physician Shortage Reduction Act, the Opioid Workforce Act, Substance Use Disorder Workforce Act, the Pathways to Practice program proposal, and the Presidents FY 2024 budget request. Advocate for the inclusion of Medicare GME funding in FY 2024 federal budget. Meet with HHS Region II to discuss GME legislation - the Resident Physician Shortage Reduction Act. Discuss Medicare and Medicaid issues with HHS Assistant Secretary for Legislation. Support delay of Medicaid DSH cuts. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss telehealth issues with Congressional staff and support for the permanent extension of PHE telehealth flexibilities. Discuss Acute Hospital Care at Home waiver and support for its permanent extension. Discuss legislation to provide support for safety net hospitals. Discuss issues concerning DSH hospitals with the Executive Branch. Meet with CMS Innovation Center to discuss CMMI models of care. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss opposition of site-neutral payment policies with Congressional staff. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities: removing Medicare geographic and originating site restrictions, expanding the list of practitioners eligible to furnish telehealth services, extending telehealth services for federally qualified health centers and rural health clinics, delaying in-person Medicare requirements related to behavioral health care, and allowing audio-only services. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support).

Advocate for inclusion of Medicare GME funding in the Presidents FY 2024 budget request. Discuss Medicare GME funding in Consolidated Appropriations Act, 2023 with Congressional staff and HHS staff. Discuss Medicare Nursing and Allied Health Education Payment Policies in Consolidated Appropriations Act, 2023 Section 4143 Implementation with House Ways and Means staff. Meeting with House Ways and Means Committee staff to discuss safety net funding issues. Meeting with CMS Regional Administration to discuss safety net funding issues.

Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including the inclusion of the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441) in appropriations legislation.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), the Substance Use Disorder Workforce Act (H.R. 3441), the Training Psychiatrist for The Future Act, and President Biden's FY 2024 Budget request. graduate medical education legislation Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House, and Congressional staff. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS. Discuss opposition to Medicare statutory PAYGO cuts with congressional staff. Discuss Medicaid waiver proposal with CMS staff. Discuss visitation issues with HHS staff. Discuss support for the Advancing Telehealth Beyond COVID-19 Act of 2021. Discuss support for the Acute Hospital Care at Home program. Support legislation to provide support for safety-net hospitals.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS, and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), the Substance Use Disorder Workforce Act (H.R. 3441) the Training Psychiatrist for the Future Act, and President Biden's FY 2024 Budget. Discuss technical assistance regarding graduate medical education legislation with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills, including the No Surprises Act (P.L. 116-260). Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with the White House and Congressional staff, including the LIFT America Act (H.R. 1848) and INVEST in America Act (H.R. 3684). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss insurance companies transactions and policies affecting health care providers with Congressional staff and support for the Improving Seniors' Timely Access to Care Act (H.R. 3173). Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS. Discuss the regulation of laboratory developed tests and the VALID Act with Congressional and committee staff. Discuss family planning funding with staff at HHS. Discuss federal climate pledge with staff at HHS. Discuss monkeypox therapeutics, FDA Commissioner Discuss support for the Hospital Inpatient Services Modernization Act (H.R. 7053) with congressional staff. Discuss FEMA reimbursement with FEMA and congressional staff.

Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including the inclusion of the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441) in appropriations legislation.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441). graduate medical education legislation Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House, and Congressional staff. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including the inclusion of the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441) in appropriations legislation.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441). graduate medical education legislation Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House, and Congressional staff. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including the inclusion of the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441) in appropriations legislation.

Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including the inclusion of the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441) in appropriations legislation.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441). graduate medical education legislation Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House, and Congressional staff. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including the inclusion of the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441) in appropriations legislation.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441). graduate medical education legislation Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House, and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS, and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS, and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441). Discuss technical assistance regarding graduate medical education legislation with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills, including the No Surprises Act (P.L. 116-260). Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with the White House and Congressional staff, including the LIFT America Act (H.R. 1848) and INVEST in America Act (H.R. 3684). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss insurance companies transactions and policies affecting health care providers with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS, and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256), the Opioid Workforce Act (S. 1438), and the Substance Use Disorder Workforce Act (H.R. 3441). graduate medical education legislation Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Elijah E. Cummings Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House, and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS, and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 1349 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256) and the Opioid Workforce Act. Discuss technical assistance regarding the Opioid Workforce Act with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 834/H.R. 2256) and the Opioid Workforce Act. Discuss technical assistance regarding the Opioid Workforce Act with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2021 (S. 909) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with the White House and Congressional staff, including in the Invest in America Act (H.R. 2). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with Congressional staff, including in the Invest in America Act (H.R. 2). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss hospital infrastructure spending with Congressional staff, including in the Invest in America Act (H.R. 2). Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss supply chain issues, including PPE and ventilators, with Congressional staff, HHS and White House. Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss surprise billing legislation with White House staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation. Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (n) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439), and its inclusion in appropriations legislative.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss the HEROES Act (H.R. 6800) and other COVID-19 phase four response legislation with lawmakers, Congressional staff, HHS and the White House. Discuss disbursements from the Public Health and Social Services Emergency Fund with HHS, the White House, and Congressional staff and lawmakers. Discuss Medicare Advance Payment forgiveness with HHS and Congressional staff, advocated for H.R. 7292 (support). Discuss a range of other COVID-19 priorities with Congressional staff including ensuring Medicare advantage plans comply with increased COVID-19 Medicare payments (support), an add-on payment for COVID-19 care (support), and crisis pay for health care workers (support). Support a delay of Medicaid DSH reimbursement cuts in COVID-19 response package and a delay or repeal of the Medicaid Fiscal Accountability Regulation. Discuss increased Federal Medical Assistance Percentages (support) and increased funding for state and local governments (support) with Congressional staff. Discuss Medicare Rule on Physician Time Studies (42 CFR 415.60) with CMS. Discuss disclosure of patient information to the media with HHS. Discuss Medicare Rules regarding new teaching hospitals with CMS. Discuss alternate care site billing with CMS.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss legislation to address drug shortages with Congressional staff and members, the MEDS Act (S. 2373) (support), advocate for its inclusion in the CARES Act (H.R. 748). Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), and the Affordable Care Act (support). Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff.

Advocate for several Medicare & Medicaid provisions in the CARES Act (H.R. 748), including a delay of Medicare sequestration cuts, a delay of the Medicare Fiscal Accountability Rule and Medicaid disproportionate share hospital (DSH) cut relief. Support increased Federal Medical Assistance Percentages (FMAP) and FMAP flexibility at the state level in the Families First Coronavirus Response Act (H.R. 6201) and the CARES Act (H.R. 748). Advocate for federal childcare benefits for members of the health care workforce. Advocate for increasing borrowing limits on SBA loans and ensuring health care providers are eligible. Support direct funding for health care providers treating COVID-19 patients, including funding through the Hospital Preparedness Program. Support funding and efforts to ensure health care providers have access to essential materials, such as PPE, for COVID-19 response and readiness. Advocate for changes to indirect medical education payments to account for COVID-19 response efforts. Advocate for direct Federal funding for state and local governments during the COVID-19 crisis. Discuss the distribution methodology for the Public Health and Social Services Emergency Fund with the White House, HHS, CMS and Congressional staff. Discuss issues related to Medicare accelerated payments with White House, HHS, CMS and Congressional staff. Advocate for continued Federal funding for New York States DSRIP program. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss COVID-19 response with White House staff and HHS leadership, including the HHS Secretary. Discuss GNYHA's legislative priorities with Congressional staff: a delay of cuts to Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2021 budget blueprint including cuts and changes to GME funding, site-neutral policies, changes to Medicare UCP and bad debt, Medicare post-acute care payments, wage index adjustments, and other Medicaid cuts. Support for the Medical liability provisions in the budget. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Support surprise billing legislation reform and work with committee and Congressional staff on a range of issues. Discussed several bills including: Protecting People from Surprise Medical Bills Act (H.R. 3502), Lower Health Care Costs Act (S. 1895), No Surprises Act (H.R. 3630) and Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826). Discussed the inclusion of surprise billing legislation in COVID-19 response legislation. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Discuss GME rural training tracks and possible reforms with Congressional staff. Discuss the ET3 model with staff from CMMI. Discuss the Medicare GME program, including issues related to oversight and transparency, with congressional staff. Spoke with CMS to review Medicare DGME policy (42 CFR 413.75) on residency counting issues Discuss provisions in the CARES Act (H.R. 748) related to health care provider liability and immunity with Congressional and committee staff. Attend cybersecurity briefing related to foreign threats with FBI. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS, the White House and Congressional staff. Discuss drug shortages related to the COVID-19 crisis with Congressional and Administration staff. Coordinate with ASPR, the Department of Defense, FEMA and the FDA on COVID-19 response efforts.

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), other issues related to 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Educate Congressional staff and lawmakers on Medicare for All. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414/S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Attend cybersecurity meeting at HHS to discuss cybersecurity in the health care sector. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss the HHS Secretarys priorities with agency staff, specifically for Region 2, including issues related to HPV vaccinations and issues concerning the Hospital Improvement Innovation Network. Discuss the issue of surprise medical bills with Congressional staff and the Congressional Budget Office. Discuss New York State's Partnership for Patients initiative with CMS contract officers. Submit formal comments letters on the Lower Health Care Costs Act (S. 1895), including the provisions related to surprise medical bills, and discussed the legislation with Congressional staff. Submit formal comments on the No Surprises Act (H.R. 3630) and discussed the legislation with Congressional staff. Discuss the Protecting People from Surprise Medical Bills Act (H.R. 3502) with Congressional staff. Discuss issues concerning DSH hospitals and hospital infrastructure needs with the Executive Branch. Discuss 405(d) Educational Programming with the HHS Office of Chief Information Officer. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss the MedPAC Review of Medicare IME payments with the MedPAC Commissioner (SSA 1186(d)). Discuss issues related to telehealth and HIT with Congressional staff, including the CONNECT for Health Act (S. 2741). Discuss issues related to telehealth and HIT with staff from CMS and the White House. Discuss issues related to Medicare Hospital Provider Agreements with staff from CMS.

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 348/H.R. 1763) and the Opioid Workforce Act (H.R. 3414S. 2439). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414/S. 2439) with committee staff. Educate Congressional staff and lawmakers on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), other issues related to 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff. Discuss issues related to telehealth and HIT with staff from CMS and the White House. Discuss issues related to Medicare Hospital Provider Agreements with staff from CMS. Discuss the MedPAC Review of Medicare IME payments with the MedPAC Commissioner (SSA 1186(d)).

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with Congressional staff. Discuss potential legislation to address drug shortages with Congressional staff. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Educate Congressional staff and lawmakers on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS final rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff, CMS and HHS. Discuss CMSs CY 2020 OPPS proposed rule with Congressional staff, CMS and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79), policy implementation, and Medicare GME regulations and other policies with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss Medicare and Medicaid issues with the CMS Administrator. Discuss proposed appropriations language related to OPTN/UNOS liver allocation reforms with Congressional staff and lawmakers. Discuss legislation related to GME rural training tracks with Congressional staff and lawmakers. Discuss the Prescription Drug Pricing Reduction Act of 2019 (S. 2543) with Congressional staff and committee staff. Discuss Lower Drug Costs Now Act (H.R.3) with Congressional staff.

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act (H.R. 3414). Discuss technical assistance regarding the Opioid Workforce Act (H.R. 3414) with committee staff. Educate congressional staff on Medicare for All. Support a delay of the Medicaid DSH cuts, including an amendment that would partially repeal the Medicaid DSH cuts. Discuss issues concerning DSH hospitals with the Executive Branch. Discuss CMSs FY 2020 IPPS proposed rule, including provisions related to the Medicare area wage index and uncompensated care, with Congressional staff and HHS. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Oppose the inclusion of language that would limit HHS and its relevant subcontractors' ability to implement liver allocation reforms. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support). Discuss the METRIC Act (H.R. 2296) with congressional staff. Discuss potential legislation to address drug shortages with congressional staff.

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act. Support a delay of the Medicaid DSH cuts. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss potential surprise billing legislation with Congressional staff and members. Support a delay of the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act.

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program. Acted as a fact witness and amicus in legal challenges to the Trump Administrations executive order (Protecting the Nation for Foreign Terrorists Entry into the United States). Sent a comment letter to the Department of Homeland Security urging the withdrawal of its public charge proposed rule, "Inadmissibility on Public Charge Grounds." (Oppose)

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Medicaid Disproportionate Share Hospital (DSH) cuts issues, including supporting the inclusion of a DSH cut delay in the Bipartisan Budget Act of 2018 (support) (H.R. 1892) and the continuation of DSH cuts in President Trumps FY 2019 Budget Proposal (oppose). Provide comments to CMS and OMB to advocate for a delay in further use of S-10 data for allocation of the Medicare DSH uncompensated care pool. Oppose legislation and regulations that would harm the 340B Drug Discount Program, including the cuts outlined in President Trumps FY 2019 Budget Proposal. Provide comments to CMS addressing payments to off-campus hospital outpatient departments. Support legislation to reverse the cuts to the 340B Drug Discount Program in CMS Final 2017 OPPS Rule, the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support) Support Federal funding for Puerto Ricos Medicaid program and for Medicaid for individuals and families displaced by hurricanes. Oppose legislation that would harm Medicaid GME programs including the Medicaid Graduate Medical Education Transparency Act (oppose). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support the inclusion of legislation to increase GME funding, the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Oppose the FY 2020-2025 Medicaid DSH cuts, and support proposals that would delay or repeal the scheduled cuts. Support legislative proposals to reverse the site-neutral provisions in the CMS OPPS final rule for 2019. Oppose 340b and site-neutral provisions in the CMS OPPS proposed and final rules for 2019. Sent comment letter to HHS regarding its OPPS proposed rule for CY 2019. The letter addressed issues related to site-neutral policies, 340B, WAC-based payments, packaging for non-opioid pain treatments, and changes to the IPO list, among other topics.

The Childrens Health Insurance Program, including the reauthorization of the program in the January 2018 continuing resolution to fund the Federal government (support) (H.R. 195) and the extension of the program in the Bipartisan Budget Act of 2018 (support) (H.R. 1892). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680).

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller-Johnson bill, and the Trump Administration's FY 2019 budget proposal. Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Advocated for individual marketplace stabilization measures, including the funding of ACA cost sharing reduction payments in standalone legislation and in FY 2018 funding legislation. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), the Medicaid Graduate Medical Education Transparency Act (oppose), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Support the inclusion of legislation to increase GME funding, the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support legislation to align 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA), The Overdose Prevention and Patient Safety Act (support) (H.R. 6082), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support the SUPPORT for Patients and Communities Act (support) (H.R. 6). Support the Opioid Crisis Response Act of 2018 (support) (S. 2680). Lobby HHS, HRSA, OPTN and UNOS on liver allocation reforms. Support liver allocation reforms, including the Fairness in Liver Allocation Act (support) (H.R. 6517). Oppose legislation to amend the National Organ Transplant Act, the National Organ Transplant Act Amendments of 2018 (oppose) (H.R. 6458), and the inclusion of language that would amend the National Organ Transplant Act in the Labor-HHS appropriations bill (H.R. 6157). Oppose the FY 2020-2025 Medicaid DSH cuts, and support proposals that would delay or repeal the scheduled cuts. Support proposals that would increase funding levels for programs related to hospital infrastructure, access to capital, workforce issues, health information technology, and telehealth. Support legislative proposals to reverse the site-neutral provisions in the CMS OPPS final rule for 2019. Oppose 340b and site-neutral provisions in the CMS OPPS proposed and final rules for 2019. Raise awareness about surprise billing laws on both the federal and state levels.

Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Oppose President Trumps FY 19 budget proposal (Efficient, Effective, Accountable: An American Budget), and it funding cuts and reforms to Federal GME programs, Medicaid uncompensated care pools, hospital outpatient departments, bad debt payments, and other hospital related provisions. The Bipartisan Budget Act of 2018 (H.R. 1892) (support) and specific hospital related provisions in the legislation, including increased funding for the National Institutes of Health (NIH) (support), disaster relief funding and increased Medicaid funding for Puerto Rico and the US Virgin Islands (support), and the inclusion of the cut to Medicare payments for hospitals that discharge patients to hospice care (oppose). Oppose House Republicans FY 2019 budget proposal (A Brighter American Future), and its funding cuts and reforms to Medicaid and Medicare, proposed reforms to federal GME programs, and efforts to repeal the Affordable Care Act (ACA). Support for provisions related to medical malpractice reform. Oppose the inclusion of language that would amend the National Organ Transplant Act in the Labor-HHS appropriations bill (H.R. 6157). Support the inclusion of language to reverse CMSs site-neutral cut in FY 2019 appropriations bills.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Oppose President Trumps FY 19 budget proposal (Efficient, Effective, Accountable: An American Budget), and it funding cuts and reforms to Federal GME programs, Medicaid uncompensated care pools, hospital outpatient departments, bad debt payments, and other hospital related provisions. The Bipartisan Budget Act of 2018 (H.R. 1892) (support) and specific hospital related provisions in the legislation, including increased funding for the National Institutes of Health (NIH) (support), disaster relief funding and increased Medicaid funding for Puerto Rico and the US Virgin Islands (support), and the inclusion of the cut to Medicare payments for hospitals that discharge patients to hospice care (oppose). Oppose House Republicans FY 2019 budget proposal (A Brighter American Future), and its funding cuts and reforms to Medicaid and Medicare, proposed reforms to federal GME programs, and efforts to repeal the Affordable Care Act (ACA). Support for provisions related to medical malpractice reform. Oppose the inclusion of language that would amend the National Organ Transplant Act in the Labor-HHS appropriations bill (H.R. 6157).

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller-Johnson bill, and the Trump Administration's FY 2019 budget proposal. Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Advocated for individual marketplace stabilization measures, including the funding of ACA cost sharing reduction payments in standalone legislation and in FY 2018 funding legislation. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Support the inclusion of legislation to increase GME funding, the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support legislation to align 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA), The Overdose Prevention and Patient Safety Act (support) (H.R. 6082), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support the SUPPORT for Patients and Communities Act (support) (H.R. 6). Support the Opioid Crisis Response Act of 2018 (support) (S. 2680). Lobby HHS, HRSA, OPTN and UNOS on liver allocation reforms. Support liver allocation reforms, including the Fairness in Liver Allocation Act (support) (H.R. 6517). Oppose legislation to amend the National Organ Transplant Act, the National Organ Transplant Act Amendments of 2018 (oppose) (H.R. 6458), and the inclusion of language that would amend the National Organ Transplant Act in the Labor-HHS appropriations bill (H.R. 6157). Oppose 340B provisions and site-neutral provisions in the CMS OPPS proposed rule for 2019.

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program. Acted as a fact witness and amicus in legal challenges to the Trump Administrations executive order (Protecting the Nation for Foreign Terrorists Entry into the United States).

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Medicaid Disproportionate Share Hospital (DSH) cuts issues, including supporting the inclusion of a DSH cut delay in the Bipartisan Budget Act of 2018 (support) (H.R. 1892) and the continuation of DSH cuts in President Trumps FY 2019 Budget Proposal (oppose). Provide comments to CMS and OMB to advocate for a delay in further use of S-10 data for allocation of the Medicare DSH uncompensated care pool. Oppose legislation and regulations that would harm the 340B Drug Discount Program, including the cuts outlined in President Trumps FY 2019 Budget Proposal. Provide comments to CMS addressing payments to off-campus hospital outpatient departments. Support legislation to reverse the cuts to the 340B Drug Discount Program in CMS Final 2017 OPPS Rule, the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support) Support Federal funding for Puerto Ricos Medicaid program and for Medicaid for individuals and families displaced by hurricanes. Oppose legislation that would harm Medicaid GME programs including the Medicaid Graduate Medical Education Transparency Act (oppose). Support legislation to repeal the Medicaid IMD exclusion, the Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act (support) (H.R. 5797), and support the inclusion of the legislation in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Support the inclusion of legislation to increase GME funding, the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), in the SUPPORT for Patients and Communities Act (support) (H.R. 6) and the Opioid Crisis Response Act of 2018 (support) (S. 2680). Oppose 340B provisions and site-neutral provisions in the CMS OPPS proposed rule for 2019.

Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program. Acted as a fact witness and amicus in legal challenges to the Trump Administrations executive order (Protecting the Nation for Foreign Terrorists Entry into the United States)

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301), the Opioid Workforce Act of 2018 (support) (H.R. 5818/S. 2843), and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 budget proposal (oppose). Medicaid Disproportionate Share Hospital (DSH) cuts issues, including supporting the inclusion of a DSH cut delay in the Bipartisan Budget Act of 2018 (support) (H.R. 1892) and the continuation of DSH cuts in President Trumps FY 2019 Budget Proposal (oppose). Provide comments to CMS and OMB to advocate for a delay in further use of S-10 data for allocation of the Medicare DSH uncompensated care pool. Oppose legislation and regulations that would harm the 340B Drug Discount Program, including the cuts outlined in President Trumps FY 2019 Budget Proposal. Provide comments to CMS addressing payments to off-campus hospital outpatient departments. Support legislation to reverse the cuts to the 340B Drug Discount Program in CMS Final 2017 OPPS Rule, the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support) Support Federal funding for Puerto Ricos Medicaid program and for Medicaid for individuals and families displaced by hurricanes. Oppose legislation that would harm Medicaid GME programs including the Medicaid Graduate Medical Education Transparency Act (oppose) Support legislation that would repeal the IMD exclusion (support) (H.R. 5797), and support the legislations inclusion in the SUPPORT for Patients and Communities Act (support) (H.R. 6)

Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.

The Childrens Health Insurance Program, including the reauthorization of the program in the January 2018 continuing resolution to fund the Federal government (support) (H.R. 195) and the extension of the program in the Bipartisan Budget Act of 2018 (support) (H.R. 1892).

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline shortages. Oppose legislation that would harm the 340B Drug Discount Program for safety net hospitals and support legislation to prevents the implementation of the cuts in CMS Final 2017 OPPS Rule (CMS-2017-0091), the SERV Communities Act (support) (H.R. 6071) and H.R. 4392 (support) Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars. Raise awareness about injectable opioid shortages, urge engagement by the Food & Drug Administration Office of Drug Shortages and approval by the Drug Enforcement Agency of CII quota requests to increase production of injectable opioid products in short supply. Submitted comments to DEA urging the revision of its quota allocation process to recognize the unique institutional needs for injectable opioids. Supported legislation to increase competition in the drug marketplace, the CREATES Act (S. 974) (support)

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Oppose President Trumps FY 19 budget proposal (Efficient, Effective, Accountable: An American Budget), and it funding cuts and reforms to Federal GME programs, Medicaid uncompensated care pools, hospital outpatient departments, bad debt payments, and other hospital related provisions. The Bipartisan Budget Act of 2018 (H.R. 1892) (support) and specific hospital related provisions in the legislation, including increased funding for the National Institutes of Health (NIH) (support), disaster relief funding and increased Medicaid funding for Puerto Rico and the US Virgin Islands (support), and the inclusion of the cut to Medicare payments for hospitals that discharge patients to hospice care (oppose).

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller-Johnson bill, and the Trump Administration's FY 2019 budget proposal. Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Advocated for individual marketplace stabilization measures, including the funding of ACA cost sharing reduction payments in standalone legislation and in FY 2018 funding legislation.

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline shortages. Oppose legislation that would harm the 340B drug discount program for safety net hospitals, and support legislation (H.R.4392) that prevents the implementation of 340B reductions finalized in the CMS outpatient rule (CMS-2017-0091). Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars. Raise awareness about injectable opioid shortages, urge approval by the Drug Enforcement Agency of CII quota requests to increase production of injectable opioid products in short supply.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to the American Health Care Act (House), the Better Care Reconciliation Act (Senate), the Graham-Cassidy-Heller-Johnson bill, and President Trumps FY 2019 Budget Proposal. Graduate Medical Education (GME) issues, including the Resident Physician Shortage Reduction Act of 2017 (support) (H.R. 2267/S. 1301) and the cuts and changes to Medicare and Medicaid GME programs in President Trumps FY 2019 Budget Proposal (oppose). Medicaid Disproportionate Share Hospital (DSH) cuts issues, including supporting the inclusion of a DSH cut delay in the Bipartisan Budget Act of 2018 (support) (H.R. 1892) and the continuation of DSH cuts in President Trumps FY 2019 Budget Proposal (oppose). Provide comments to CMS and OMB to advocate for a delay in further use of S-10 data for allocation of the Medicare DSH uncompensated care pool. Oppose legislation and regulations that would harm the 340B Drug Discount Program, including the cuts outlined in President Trumps FY 2019 Budget Proposal. Provide comments to CMS addressing payments to off-campus hospital outpatient departments. Support legislation to reverse the cut to the 340B Drug Discount Program in CMS Final 2018 OPPS rule (H.R. 4392). Support Federal funding for Puerto Ricos Medicaid program and for Medicaid for individuals and families displaced by hurricanes.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and Better Care Reconciliation Act (Senate) (budget reconciliation bill, H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Oppose funding cuts for the NIH included in President Trumps FY 18 budget proposal (America First: A Budget Blueprint to Make America Great Again). Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House), the Better Care Reconciliation Act (Senate) (H.R. 1628), the Graham-Cassidy-Heller bill, and the FY 2017 budget resolution (S. Con. Res. 3). Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Provided comments to SAMHSA regarding its final rule modifying the regulations at 42 CFR Part 2. Advocate for continuation of ACA CSR subsidy payments. Support for streamlining HIPAA requirements in a letter to the HHS Office for Civil Rights. Comments on the FY 2018 IPPS proposed rule (CMS-1677-P) re: electronic health record incentive program modifications. Educated staff from the Office of Civil Rights at HHS about the complexities of Federal and State HIPAA and privacy laws and how they inhibit legitimate information sharing.

Oppose provisions contained in the Tax Cuts and Jobs Act (H.R. 1), including provisions related to private activity bonds, the individual insurance mandate repeal, executive compensation, medical deductions, education and child care exclusions, and state and local tax deductibility.

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases, including raising awareness about saline shortages. Oppose legislation that would harm the 340B drug discount program for safety net hospitals, and support legislation (H.R.4392) that prevents the implementation of 340B reductions finalized in the CMS outpatient rule (CMS-2017-0091). Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214), and support other pro-competition policies, including legislation that would prohibit evergreening and abuse of citizen petitions, and promote the growth of biosimilars.

Support legislation to continue funding for the Child Health Insurance Program.

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (House) and the Better Care Reconciliation Act (Senate) (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (support) (H.R.2267/S.1301). Oppose the continuation of Medicaid Disproportionate Share Hospital (DSH) cuts. The Empire State Equity Act (H.R. 2088) - support. Provide comments to CMS on the Medicare IPPS FY 2018 proposed rule (CMS-1677-P), advocate for a delay of proposed rule section dealing with DSH uncompensated care pool, and comments regarding Medicare quality reporting program proposals. Hospital and Medicaid issues related to FY 2018 proposed budget resolution, "A New Foundation for American Greatness" -- oppose. Oppose legislation and regulations that would harm 340B program, including proposal in the 2018 proposed OPPS rule (CMS-1678-P) reducing Medicare reimbursment for certain 340B drugs. Provided comments to CMS on the 2018 OPPS proposed rule (CMS-1678-P) addressing payments to off-campus hospital outpatient departments. Support Federal funding for Puerto Rico's Medicaid program and for Medicaid for individuals and families displaced by hurricanes (H.R.2266 - Additional Supplemental Appropriations for Disaster Relief Requirements Act, 2017, H.R.601 - Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017.)

Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases. Support drug pricing legislation that would promote competition by fast tracking generic drug applications (H.R. 749/S.297). Oppose legislation that would harm the 340B drug discount program for safety net hospitals. Support reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214)

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act (ACA), including opposition to The American Health Care Act (House) and the Better Care Reconciliation Act (Senate) (H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system. Discussions with HHS and DHS regarding cybersecurity issues. Provided comments to SAMHSA regarding its final rule modifying the regulations at 42 CFR Part 2. Advocate for continuation of ACA CSR subsidy payments.

Hospital and Medicaid issues related to repeal and replace of the Affordable Care Act, including opposition to The American Health Care Act (budget reconciliation bill, H.R. 1628) and the FY 2017 budget resolution (S. Con. Res. 3). Oppose funding cuts for the NIH included in President Trumps FY 18 budget proposal (America First: A Budget Blueprint to Make America Great Again).

Oppose parts of the Executive Order (Protecting the Nation from Foreign Terrorists Entry into the United States) with a focus on its impact on residency training and teaching hospitals. Provided comments regarding the suspension of the H1-B visa Premium Processing program.

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support; support for Zika supplemental funding; The Living Donor Protection Act of 2016 (H.R.4616/S.2584) - support; The Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 2745) - support; proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose; Congressional letter supporting reforms to the liver transplant allocation system - support; discussions with HHS regarding how to handle cybersecurity issues; hospital issues related to repeal and replace of the Affordable Care Act; Senate Finance Committee guidance on concurrent surgeries.

House and Senate Budget Resolutions, provisions relating to Medicare reductions - oppose (H.Con.Res. 27, S.Con.Res.11)

Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (H.R.2124/S.1148) - support); provided comments to Congress in response to Energy and Commerce Committee request for input on GME; amendments to the Medicare hospital re-admissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.1343/S.688 - support; proposals to amend the 2 midnight policy - support; hospital issues included in President Obama's FY 16 budget - oppose; hospital issues included in H.R.2, the Medicare Access and CHIP Re-authorization Act of 2015 - support; legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; Strengthening Medicare Advantage through Innovation and Transparency for Seniors (H.R.2570) - oppose; Medicare Inpatient Prospective Payment System FY 2016 proposed rule (CMS 1632-P) - detailed comment letter; legislation to improve the recovery audit contractor program (H.R.2156); Audit and Appeal Fairness, Integrity and Reforms in Medicare Act (AFIRM) - provided comments to the Senate Finance Committee; Ensuring Seniors Access to Local Pharmacies Act of 2015 (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Act (S.776) - support; CMS-4159-F2 - comments on daily dispensing fees; Medicare Independence at Home Medical Practice Demonstration Improvement Act of 2015 (P.L.114-39) - support; provided comments on the proposed Medicare outpatient prospective payment system rule (CMS-1633-P); Medicare IME Pool Act of 2015 (H.R.3292) - oppose; Strengthening DSH and Medicare through Subsidy Recapture and Payment Reform Act (H.R.3288) - oppose; Medicare Crosswalk Hospital Code Development Act (H.R. 3291) - oppose; sign-on letter to CMS urging it to reconsider negative update for CY 2016 (CMS-1633-P) - support; proposed Medicare and Medicaid cuts as offsets to pay for budget increases, raising the debt ceiling, etc. - oppose; site neutral hospital outpatient cuts and other hospital related provisions included in the Bipartisan Budget Act of 2015 (H.R. 1314) - oppose; legislative proposals (H.R. 5273)and Congressional letters to amend the Bipartisan Budget Acts site neutral hospital outpatient payment cut to grandfather sites under development as well as other legislative changes (support) - advocated for their inclusion in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029); provided comments to Congress regarding provisions in the Mental Health Reform Act of 2015 (S. 1945), that would reform how health care information for substance abuse patients is shared; met with HHS officials on Medicare and Medicaid issues of importance to the Commonwealth of Puerto Rico and Puerto Rican health care providers; submitted comments on Medicare and Medicaid Programs: Reform of Requirements for Long-Term Care Facilities (CMS-3260-P); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913) - support (with some concerns about pharmacy lock-in policy); hospital issues included in House FY 17 budget - oppose; hosptial issues included in President Obama's FY 17 budget proposal - oppose; provided comments in response to Energy and Commerce Committee request for input on hospital site-neutral issues; Medicaid provisions included in the Common Sense Savings Act of 2016 (H.R.4725) - oppose; provided comments to CMS and Congress regarding the Hospital Compare Star Ratings for hospitals - support for delay and fixing measures; The Fair Medicare Hospital Payments Act of 2016 (H.R. 4428) - oppose; provided comments to CMS on hospital site-neutral proposals - argued for flexibility in the anticipated OPPS proposed rule; provided comments to CMS on the FY 17 IPPS proposed rule (CMS-1655-P) with a focus on opposition to the proposed Medicare DSH policy and provided input to Capitol Hill and the Administration;submitted comments on Medicaid Program,Covered Outpatient Drugs (CMS-2345-FC); asked Congressional members to urge CMS to finalize its 2014 proposed guidance to Part D drug plans and PBMs regarding consistent reporting of Direct and Indirect Remuneration (DIR); Improving Transparency & Accuracy in Medicare Part D Spending (S.3308/H.R.5957) - support; testified at House Ways and Means Health Subcommittee hearing entitled "Incentivizing Quality Outcomes in Medicare Part A" in support of streamlining hospital measures and reporting; provided comments regarding the Medicare OPPS CY2017 proposed rule (81 FR 45603), in particular in opposition to implementation of site-neutral proposals; provided comments on Merit Based Incentive Payment System (MIPS)and Alternative Payment Models (APMs) under MACRA 2015 (81 FR 28161); discussions with CMS regarding priority categories for redistribution of Medicare-funded residency slots; discussions with CMS to encourage consistency in hospital surveys; submitted comments on the Part B Drug Payment Model proposed rule (CMS-1670-P) - serious concerns; submitted comments on the SNF PPS proposed rule (CMS-1645-P) - serious concerns; Texas proposed Medicaid State Plan Amendment (15-005) in response to the CMS Covered Outpatient Drug Rule (CMS-2345-FC) - concerns; submitted comments to CMS about its proposal to expand testing of mandatory, risk-based bundled payments for acute episodes of care - oppose; 21st Century Cures Act (H.R. 34, now P.L.114-255) provisions that apply to site neutral, readmissions, and other hospital reimbursement issue - support.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases and support draft reform legislation; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment, oppose use of savings from home infusion payment reform for purposes other than creating a Medicare home infusion benefit; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments and Capitol Hill meetings on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6) - support; proposed amendments to 340b program (not ultimately included in H.R.6) - oppose; provide comments on proposed 340b omnibus guidance (RIN 0906 AB08); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913)- support (with some concerns about pharmacy lock-in policy); submitted comments on Management Standards for Hazardous Waste Pharmaceuticals (EPA-HQ-RCRA-2007-0932); meeting with DEA on Controlled Substances Act (21 USC 802); proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose; Comprehensive Addiction and Recovery Act of 2016 ((S.524), monitoring for pharmacy lock-in policy, which includes exemption for LTC) - support; Increasing Competition in Pharmaceuticals Act (S.2615/H.R.4784) - support; CREATES Act addressing REMS abuses (S.3056) - support.

House and Senate Budget Resolutions, provisions relating to Medicare reductions - oppose (H.Con.Res. 27, S.Con.Res.11)

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support; support for Zika supplemental funding; The Living Donor Protection Act of 2016 (H.R.4616/S.2584) - support; The Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 2745) - support; proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose; Congressional letter supporting reforms to the liver transplant allocation system - support; discussions with HHS regarding how to handle cybersecurity issues.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases and support draft reform legislation; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments and Capitol Hill meetings on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6) - support; proposed amendments to 340b program (not ultimately included in H.R.6) - oppose; provide comments on proposed 340b omnibus guidance (RIN 0906 AB08); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913)- support (with some concerns about pharmacy lock-in policy); submitted comments on Management Standards for Hazardous Waste Pharmaceuticals (EPA-HQ-RCRA-2007-0932); meeting with DEA on Controlled Substances Act (21 USC 802); proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose; Comprehensive Addiction and Recovery Act of 2016 ((S.524),monitoring for pharmacy lock-in policy, which includes exemption for LTC)- support; Increasing Competition in Pharmaceuticals Act (S.2615)- support.

Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (H.R.2124/S.1148) - support); provided comments to Congress in response to Energy and Commerce Committee request for input on GME; amendments to the Medicare hospital re-admissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.1343/S.688 - support; proposals to amend the 2 midnight policy - support; hospital issues included in President Obama's FY 16 budget - oppose; hospital issues included in H.R.2, the Medicare Access and CHIP Re-authorization Act of 2015 - support; legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; Strengthening Medicare Advantage through Innovation and Transparency for Seniors (H.R.2570) - oppose; Medicare Inpatient Prospective Payment System FY 2016 proposed rule (CMS 1632-P) - detailed comment letter; legislation to improve the recovery audit contractor program (H.R.2156); Audit and Appeal Fairness, Integrity and Reforms in Medicare Act (AFIRM) - provided comments to the Senate Finance Committee; Ensuring Seniors Access to Local Pharmacies Act of 2015 (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Act (S.776) - support; CMS-4159-F2 - comments on daily dispensing fees; Medicare Independence at Home Medical Practice Demonstration Improvement Act of 2015 (P.L.114-39) - support; provided comments on the proposed Medicare outpatient prospective payment system rule (CMS-1633-P); Medicare IME Pool Act of 2015 (H.R.3292) - oppose; Strengthening DSH and Medicare through Subsidy Recapture and Payment Reform Act (H.R.3288) - oppose; Medicare Crosswalk Hospital Code Development Act (H.R. 3291) - oppose; sign-on letter to CMS urging it to reconsider negative update for CY 2016 (CMS-1633-P) - support; proposed Medicare and Medicaid cuts as offsets to pay for budget increases, raising the debt ceiling, etc. - oppose; site neutral hospital outpatient cuts and other hospital related provisions included in the Bipartisan Budget Act of 2015 (H.R. 1314) - oppose; legislative proposals (H.R. 5273)and Congressional letters to amend the Bipartisan Budget Acts site neutral hospital outpatient payment cut to grandfather sites under development as well as other legislative changes (support) - advocated for their inclusion in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029); provided comments to Congress regarding provisions in the Mental Health Reform Act of 2015 (S. 1945), that would reform how health care information for substance abuse patients is shared; met with HHS officials on Medicare and Medicaid issues of importance to the Commonwealth of Puerto Rico and Puerto Rican health care providers; submitted comments on Medicare and Medicaid Programs: Reform of Requirements for Long-Term Care Facilities (CMS-3260-P); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913) - support (with some concerns about pharmacy lock-in policy); hospital issues included in House FY 17 budget - oppose; hosptial issues included in President Obama's FY 17 budget proposal - oppose; provided comments in response to Energy and Commerce Committee request for input on hospital site-neutral issues; Medicaid provisions included in the Common Sense Savings Act of 2016 (H.R.4725) - oppose; provided comments to CMS and Congress regarding the Hospital Compare Star Ratings for hospitals - support for delay and fixing measures; The Fair Medicare Hospital Payments Act of 2016 (H.R. 4428) - oppose; provided comments to CMS on hospital site-neutral proposals - argued for flexibility in the anticipated OPPS proposed rule; provided comments to CMS on the FY 17 IPPS proposed rule (CMS-1655-P) with a focus on opposition to the proposed Medicare DSH policy and provided input to Capitol Hill and the Administration;submitted comments on Medicaid Program,Covered Outpatient Drugs (CMS-2345-FC); asked Congressional members to urge CMS to finalize its 2014 proposed guidance to Part D drug plans and PBMs regarding consistent reporting of Direct and Indirect Remuneration (DIR).

Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (H.R.2124/S.1148) - support); provided comments to Congress in response to Energy and Commerce Committee request for input on GME; amendments to the Medicare hospital re-admissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.1343/S.688 - support; proposals to amend the 2 midnight policy - support; hospital issues included in President Obama's FY 16 budget - oppose; hospital issues included in H.R.2, the Medicare Access and CHIP Re-authorization Act of 2015 - support; legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; Strengthening Medicare Advantage through Innovation and Transparency for Seniors (H.R.2570) - oppose; Medicare Inpatient Prospective Payment System FY 2016 proposed rule (CMS 1632-P) - detailed comment letter; legislation to improve the recovery audit contractor program (H.R.2156); Audit and Appeal Fairness, Integrity and Reforms in Medicare Act (AFIRM) - provided comments to the Senate Finance Committee; Ensuring Seniors Access to Local Pharmacies Act of 2015 (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Act (S.776) - support; CMS-4159-F2 - comments on daily dispensing fees; Medicare Independence at Home Medical Practice Demonstration Improvement Act of 2015 (P.L.114-39) - support; provided comments on the proposed Medicare outpatient prospective payment system rule (CMS-1633-P); Medicare IME Pool Act of 2015 (H.R.3292) - oppose; Strengthening DSH and Medicare through Subsidy Recapture and Payment Reform Act (H.R.3288) - oppose; Medicare Crosswalk Hospital Code Development Act (H.R. 3291) - oppose; sign-on letter to CMS urging it to reconsider negative update for CY 2016 (CMS-1633-P) - support; proposed Medicare and Medicaid cuts as offsets to pay for budget increases, raising the debt ceiling, etc. - oppose; site neutral hospital outpatient cuts and other hospital related provisions included in the Bipartisan Budget Act of 2015 (H.R. 1314) - oppose; legislative proposals and Congressional letters to amend the Bipartisan Budget Acts site neutral hospital outpatient payment cut to grandfather sites under development as well as other legislative changes (support) - advocated for their inclusion in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029); provided comments to Congress regarding provisions in the Mental Health Reform Act of 2015 (S. 1945), that would reform how health care information for substance abuse patients is shared; met with HHS officials on Medicare and Medicaid issues of importance to the Commonwealth of Puerto Rico and Puerto Rican health care providers; submitted comments on Medicare and Medicaid Programs: Reform of Requirements for Long-Term Care Facilities (CMS-3260-P); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913) - support (with some concerns about pharmacy lock-in policy); hospital issues included in House FY 17 budget - oppose; hosptial issues included in President Obama's FY 17 budget proposal - oppose; provided comments in response to Energy and Commerce Committee request for input on hospital site-neutral issues; Medicaid provisions included in the Common Sense Savings Act of 2016 (H.R.4725) - oppose; provided comments to CMS and Congress regarding the Hospital Compare Star Ratings for hospitals - support for delay and fixing measures; The Fair Medicare Hospital Payments Act of 2016 (H.R. 4428) - oppose.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases and support draft reform legislation; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments and Capitol Hill meetings on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6) - support; proposed amendments to 340b program (not ultimately included in H.R.6) - oppose; provide comments on proposed 340b omnibus guidance (RIN 0906 AB08); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913)- support (with some concerns about pharmacy lock-in policy); submitted comments on Management Standards for Hazardous Waste Pharmaceuticals (EPA-HQ-RCRA-2007-0932); meeting with DEA on Controlled Substances Act (21 USC 802); proposed changes to regulation of Laboratory Developed Tests (FDA-2011-D-0360-Draft Guidance for Industry, Food and Drug Administration Staff and Clinical Laboratories: Framework for Regulatory Oversight of Laboratory Developed Tests) - oppose.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6) - support; proposed amendments to 340b program (not ultimately included in H.R.6) - oppose; provide comments on proposed 340b omnibus guidance (RIN 0906 AB08); Stopping Medication Abuse and Protecting Seniors Act of 2015 (S.1913)- support (with some concerns about pharmacy lock-in policy); submitted comments on Management Standards for Hazardous Waste Pharmaceuticals (EPA-HQ-RCRA-2007-0932); meeting with DEA on Controlled Substances Act (21 USC 802)

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials; Ebola funding language including in the Consolidated Appropriations Act of 2016 (Omnibus legislation/Senate amendment to H.R. 2029) - support.

House and Senate Budget Resolutions, provisions relating to Medicare reductions - oppose (H.Con.Res. 27, S.Con.Res.11)

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6) - support; proposed amendments to 340b program (not ultimately included in H.R.6) - oppose; provide comments on proposed 340b omnibus guidance (RIN 0906 AB08).

Support House and Senate proposal for re-authorization of the Terrorism Risk Insurance Act (H.R.26).

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524 - comments on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose

Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act - support); provided comments to Congress in response to Energy and Commerce Committee request for input on GME; amendments to the Medicare hospital re-admissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.1343/S.688 - support; proposals to amend the 2 midnight policy - support; hospital issues included in President Obama's FY 16 budget - oppose; hospital issues included in H.R.2, the Medicare Access and CHIP Re-authorization Act of 2015 - support; legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support.

Support and protect the FHA hospital and nursing home mortgage insurance programs.

Support Senate proposal for re-authorization of the Terrorism Risk Insurance Act (S.2244).

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system, advocated in support of House and Senate letters in support; H.R.83, Consolidated and Further Continuing Appropriations Act of 2015, support Ebola funding for hospital preparedness and treatment activities; sepsis (ensuring that if new Federal rules are put into place they are not inconsistent with what NY hospitals are required to do under NYS law); Flexibility in Health IT Reporting Act of 2014 (H.R.5481) - support; educating members of Congress about hospital price transparency issues; Affordable Care Act - support for coverage expansions and delivery system reforms; veterans health care, support for prompt payment provisions (H.R.3230/H.R.4810)

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; opposing the current HRSA guidance on the 340b drug pricing GPO exclusion (HRSA Release 2013-1); opposing taxes on mobile health applications (FDA mobile health guidance and regulatory risk-based framework, FDA-2011-D-0530, FDA-2014-N-0339); comments on regulations affecting point-of-use care for glucose monitoring systems (FDA-2013-D-1445); educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.5435) - support; comments on Medicare physician services pertaining to non-face-to-face chronic care management services (CMS-1612-P); reforming the durable medical equipment competitive bidding program; and hospice medication coverage reforms.

Medicare and Medicaid disproportionate share hospital (DSH) cuts, including DSH Reduction Relief Act - support amendments to mitigate the impact of cuts on losing hospitals; Graduate Medical Education issues (including Resident Physician Shortage Reduction Act (S.577/H.R.1180) - support; NYS MRT Waiver (support approval of); Amendments to the Medicare hospital readmission penalty program methodology (providing SES adjustments), H.R.4188/S.2501 - support; IMPACT Act (S.2553/H.R. 4994), support reducing burdensome hospital requirements in original bill, support of final bill; Medicare Audit Improvement Act (H.R.1250/S.1012) and other issues related to Medicare claims appeal backlogs - support; Proposals to amend the 2 Midnight Policy (CMS-1599-F) (H.R.3698/S2082) - support, as well as other proposals to create a short inpatient stay payment method (DRG refinement); CMS Disallowance to NYS File No.: NY-2014-03-MAP - oppose; Outpatient Medicare proposed rule for FY2015 - detailed comment letter on various provisions of importance to hospitals; legislation to create a comprehensive Medicare home infusion benefit (HR5435) - support; and comments on physician services pertaining to non-face-to face chronic care management services (CMS- 1612-P).

Support and protect the FHA hospital and nursing home mortgage insurance programs

Support Senate proposal for re-authorization of the Terrorism Risk Insurance Act (S.2244).

ACA (P.L.111-48, 111-152), issues related to coverage for uninsured and delivery system and reimbursement reforms; organ donation issues; issues related to immigration reform; issues related to hospital price transparency; issues related to veterans' access to health care services (H.R.3230/H.R.4810; issues related to the reauthorization of the Terrorism Risk Insurance Act (TRIA)

FHA hospital and nursing home mortgage insurance programs -- support

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance and regulatory risk-based framework (FDA-2011-D-0530 and FDA-2014-N-0339); regulations affecting point-of-use care for glucose monitoring systems (FDA-2013-D-1445); ongoing pharmaceutical issues pertaining to drug shortages and significant price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); maximum allowable cost price transparency (CMS-4159-P).

Deductibility of mobile health as eligible expenses for tax purposes (2012-13 Priority Guidance Plan: Regulations Under Code Section 213); medical device tax (FR Doc. 2012-29628).

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; organ donation issues; issues related to Superstorm Sandy and the supplemental appropriations bills; issues related to immigration reform; issues related to hospital price transparency.

Deductibility of mobile health as eligible expenses for tax purposes (2012-13 Priority Guidance Plan: Regulations Under Code Section 213); medical device tax (FR Doc. 2012-29628).

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; organ donation issues; issues related to Superstorm Sandy and the supplemental appropriations bills; issues related to immigration reform; issues related to hospital price transparency.

FHA health care loan insurance programs

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation, implementation of P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); drug compounding bills (S.959, H.R.2090, H.R.3204); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance (FDA-2011-D-0530); andtrack and trace bills (S.957 &H.R.1919).

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation, implementation of P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); drug compounding bills (S.959, H.R.2090, H.R.3204); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance (FDA-2011-D-0530); andtrack and trace bills (S.957 &H.R.1919).

FHA health care loan insurance programs

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation, implementation of P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs); drug compounding bills (S.959 & H.R.2090); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance (FDA-2011-D-0530); track and trace bills (S.957 &H.R.1919).

House Budget Resolution (H.Con.Res. 25), provisions related to Medicaid and Medicare; Senate Budget Resolution (S.Con.Res. 8), provisions relating to Medicaid and Medicare; Affordable Care Act (P.L. 111-148, P.L. 111-52), provisions affecting hospital reimbursement, including DSH; The Resident Physician Shortage Reduction Act of 2013 (S.577); Federal Medicaid 1115 Waiver issues; Medicare payments for hospital observation stays; The Resident Physician Shortage Reduction Act of 2013 (H.R. 1180);Medicare outpatient hospital payments; the American Taxpayer Relief Act (H.R. 8), provisions related to Medicare hospital reimbursement, Medicaid, and charitable contributions; The Medicare Audit Improvement Act of 2013 (H.R. 1250/S.1012); issues related to sequestration and reimbursement cuts to hospitals; issues related to the Medicare sustainable growth rate formula; the nomination of Marilyn Tavenner to be Administrator of CMS; issues related to Medicare outlier payments; President Obama's FY 2014 budget proposal, provisions related to hospital reimbursement; issues related to Medicare and Medicaid Disproportionate Share Hospital payment changes (CMS-1599-P, IPPS proposed rule)

House Budget Resolution (H.Con.Res. 25), provisions related to Medicaid and Medicare; Senate Budget Resolution (S.Con.Res. 8), provisions relating to Medicaid and Medicare; Affordable Care Act (P.L. 111-148, P.L. 111-52), provisions affecting hospital reimbursement, including DSH; The Resident Physician Shortage Reduction Act of 2013 (S.577); Federal Medicaid 1115 Waiver issues; Medicare payments for hospital observation stays; The Resident Physician Shortage Reduction Act of 2013 (H.R. 1180);Medicare outpatient hospital payments; the American Taxpayer Relief Act (H.R. 8), provisions related to Medicare hospital reimbursement, Medicaid, and charitable contributions; The Medicare Audit Improvement Act of 2013 (H.R. 1250); issues related to sequestration and reimbursement cuts to hospitals; issues related to the Medicare sustainable growth rate formula; the nomination of Marilyn Tavenner to be Administrator of CMS; issues related to Medicare outlier payments.

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5; Equal Access and Parity for Multi-Campus Hospitals Act (H.R. 2500)); discussion with Congress to support CMMI application to be designated a Hospital Engagement Contractor under the Partnership for Patients Program; organ donation issues; and The Taking Essential Steps for Testing Act (H.R. 6118); issues related to Superstorm Sandy and the supplemental appropriations bills.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187); issues related to unique device identification; issues related to drug compounding overisth by Congress; issues related to group purchasing organizations and a letter sent by Congressman Markey regarding drug shortages.

House Budget Resolution (H.Con.Res. 112), provisions related to Medicaid and Medicare; President Obama's FY 2013 Budget, provisions related to Medicaid provider taxes, DSH, Medicare Independent Payment Advisory Board, graduate medical education, bad debt; Affordable Care Act (P.L. 111-148, P.L. 111-52), provisions affecting hospital reimbursement; Improving Physician Access in Teaching Hospitals Act (H.R. 2224); H.R. 5, the Protecting Access to Healthcare Act, provisions relating to Medicare and medical malpractice; The Resident Physician Shortage Reduction Act of 2011 (S.1627); The Budget Control Act of 2011 (S.365, P.L. 112-25); Middle Class Tax Relief and Job Creation Act of 2011 (H.R.3630), provisions relating to Medicare hospital reimbursement; Temporary Payroll Tax Cut Continuation Act of 2011 (H.R. 3765); H.R. 3519, a bill to exempt the Medicare program from fallback sequestration; President Obama's deficit reduction recommendations to the Supercommittee; conference agreement to H.R. 3630, provisions relating to Medicare hospital reimbursement and Medicaid payments to states; Highway and Student Loan converence agreement (H.R.4348), provisions relating to Medicaid provider taxes and pension rules; Sequester Replacement Reconciliation Act of 2012 (H.R.5652, provisions relating to Medicare hospital reimbursement and Medicaid payments to states; Graduate Medical Education Reform Act of 2012 (S.3201); Federal Medicaid 1115 Waiver issues; Medicare payments for hospital observation stays; CMS-1588-P Medicare Program proposed rule, Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2013 Rates, including Medicare coding offset proposed cut; The Resident Physician Shortage Reduction Act of 2012 (H.R. 6562); Medicare outpatient hospital payments; Congressional activities related to the IOM Committee on Governance and Financing of GME; the American Taxpayer Relief Act (H.R. 8), provisions related to Medicare hospital reimbursement, Medicaid, and charitable contributions; The Medicare Audit Improvement Act of 2012 (H.R. 6575).

The HEALTH Act (H.R. 5) and the Protecting Access to Healthcare Act (H.R. 5, as modified), provisions related to medical malpractice reform.

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5; Equal Access and Parity for Multi-Campus Hospitals Act (H.R. 2500)); discussion with Congress to support CMMI application to be designated a Hospital Engagement Contractor under the Partnership for Patients Program; organ donation issues; and The Taking Essential Steps for Testing Act (H.R. 6118).

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5; Equal Access and Parity for Multi-Campus Hospitals Act (H.R. 2500)); discussion with Congress to support CMMI application to be designated a Hospital Engagement Contractor under the Partnership for Patients Program; organ donation issues.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187).

The HEALTH Act (H.R. 5) and the Protecting Access to Healthcare Act (H.R. 5, as modified), provisions related to medical malpractice reform.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations.

The HEALTH Act (H.R. 5) and the Protecting Access to Healthcare Act (H.R. 5, as modified), provisions related to medical malpractice reform.

The HEALTH Act (H.R. 5), provisions related to medical malpractice reform.

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5; Equal Access and Parity for Multi-Campus Hospitals Act (H.R. 2500)); discussion with Congress to support CMMI application to be designated a Hospital Engagement Contractor under the Partnership for Patients Program; Quality Care for Moms and Babies Act (H.R. 3620).

The HEALTH Act (H.R. 5), provisions related to medical malpractice reform.

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), medical device pricing issues, and preserving access to group purchasing organizations.

USCIS Interim Procedures for hospitals seeking H-1B visas.

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5; Equal Access and Parity for Multi-Campus Hospitals Act (H.R. 2500)).

The HEALTH Act (H.R. 5), provisions related to medical malpractice reform.

Affordable Care Act (P.L. 111-148, 111-152) issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms ; health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5).

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590, P.L. 111-148; H.R.4872, P.L. 111-152); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239); H.R.4213)

Health Care Reform Issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms (the American Health Care Choices Act (S.1679); Affordable Health Care for America Act (H.R.3962); Patient Protection and Affordable Health Care Act (H.R.3590, P.L. 111-148) Health Care & Education Affordability Reconciliation Act (H.R. 4872, P.L. 111-152); health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5); H.R. 4851, S. 3153, H.R. 4213; CMS-0033-F, H.R. 6072, S. 3708)).

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788)); Medical malpractice reform issues (in various health care reform proposals (including the American Health Care Choices Act (S. 1679); Patient Protection and Affordable Care Act (H.R.3590, P.L.111-148); Affordable Health Care for America Act (H.R. 3962); and stand-alone medical malpractice legislation (H.R. 1086; H.R. 3459); Fraud legislation (S.3632).

Health Care Reform Issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms (the American Health Care Choices Act (S.1679); Affordable Health Care for America Act (H.R.3962); Patient Protection and Affordable Health Care Act (H.R.3590, P.L. 111-148) Health Care & Education Affordability Reconciliation Act (H.R. 4872, P.L. 111-152); health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5); H.R. 4851, S. 3153, H.R. 4213; CMS-0033-F, H.R. 6072, S. 3708)).

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788)); Medical malpractice reform issues (in various health care reform proposals (including the American Health Care Choices Act (S. 1679); Patient Protection and Affordable Care Act (H.R.3590, P.L.111-148); Affordable Health Care for America Act (H.R. 3962); and stand-alone medical malpractice legislation (H.R. 1086; H.R. 3459); Fraud legislation (S.3632).

Medicare hospital reimbursement issues and Medicare graduate medical education reimbursement issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5) provisions related to moratorium on Medicare capital IME regulation (CMS 1390-F, CMS-1406-P), Medicare HIT investments and requirements; 42 CFR 413.79; President Obama proposals on Medicare bundled payments, reimbursement for readmissions, value-based purchasing (Budget Resolutions, H Con Res 312, S Con Res 70); Resident Physician Shortage Reduction Act (H.R. 2251/S. 973); Medicare provisions in various health care reform proposals (including disproportionate share hospital, GME, bundling, readmissions, value-based purchasing, wage index, market basket, gainsharing, and other provisions in the Affordable Health Care for America Act (H.R.3962); Patient Protection and Affordable Care Act (H.R.3590, P.L. 111-148)); and Health Care and Education Affordability Reconciliation Act of 2010 (H.R. 4872), P.L. 111-152); Medicare Commission legislation (S.1110, S. 1380, H.R.2718), provisions that would empower a Commission to implement Medicare policy changes; geographic variation legislation (H.R. 2844, H.R. 2919, H.R. 2921, H.R. 2201, S.Amdt. 887) affecting hospitals and/or physician payment policy; value-based purchasing legislation (H.R. 1776); other workforce legislation (H.R. 1946, S.1569)); Puerto Rico Medicare Parity (H.R. 2680, H.R. 1501, H.R.1502); Medicare physician payment adjustment (HR. 3961, S.1776, H.R.3326, H.R. 3590, H.R. 4851, S. 3153, H.R. 4213); Section 508 wage index extension and gainsharing extension (H.R. 4213); HIT incentive payment legislation affecting hospitals and physicians in response to proposed rule CMS-0033-P (H.R. 4851, S. 3153, H.R. 4213); Medicare 72-hour payment window limitation (H.R.4213); and HIT incentive payments and meaningful use requirements in proposed rule CMS-0033-P. Medicaid issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L.111-5) and ARRA FMAP Extension (H.R. 4263, H.R. 2847, H.R.4213) provisions related to the Federal Medical Assistance Percentage, provisions related to disproportionate share hospitals, moratoria on Medicaid regulations (CMS-2258-FC,CMS-2279-P, CMS-2213-P, CMS-2275-F, CMS-2287-P), and HIT investments; Medicaid provisions in various health care reform proposals (including the American Health Care Choices Act (Senate HELP Committee bill (S.1679), Affordable Helahtcare for America Act (H.R. 3962), Patient Protection and Affordable Care Act (H.R. 3590, P.L. 111-148), and the Health and Education Affordability Reconciliation Act of 2010 (H.R. 4872, P.L. 111-152)), including disproportionate share hospital and FMAP provisions; New York State 1115 Medicaid waiver Partnership Plan extension (11-W-00114/2) provisions related to hospitals; the Medicaid Emergency Psychiatric Care Demonstration Project Act of 2009 (S.1130/H.R.1415); Medicaid incentives for HIV screening (H.R. 3091/S.1446)); HIT incentive payment legislation affecting hospitals and physicians in response to proposed rule CMS-0033-P (H.R. 4851, S. 3153, H.R. 4213); and HIT incentive payments and meaningful use requirements in proposed rule CMS-0033-P.

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788)); Medical malpractice reform issues (in various health care reform proposals (including the American Health Care Choices Act (S. 1679); Patient Protection and Affordable Care Act (H.R.3590); Affordable Health Care for America Act (H.R. 3962); and stand-alone medical malpractice legislation (H.R. 1086; H.R. 3459).

Medicare hospital reimbursement issues and Medicare graduate medical education reimbursement issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5) provisions related to moratorium on Medicare capital IME regulation (CMS 1390-F, CMS-1406-P), Medicare HIT investments and requirements; 42 CFR 413.79; President Obama proposals on Medicare bundled payments, reimbursement for readmissions, value-based purchasing (Budget Resolutions, H Con Res 312, S Con Res 70); Resident Physician Shortage Reduction Act (H.R. 2251/S. 973); Medicare provisions in various health care reform proposals (including disproportionate share hospital, GME, bundling, readmissions, value-based purchasing, wage index, market basket, gainsharing, and other provisions in the Affordable Health Care for America Act (H.R.3962); Patient Protection and Affordable Care Act (H.R.3590)); and Health Care and Education Reconciliation Act of 2010 (H.R. 4872)); Medicare Commission legislation (S.1110, S. 1380, H.R.2718), provisions that would empower a Commission to implement Medicare policy changes; geographic variation legislation (H.R. 2844, H.R. 2919, H.R. 2921, H.R. 2201, S.Amdt. 887) affecting hospitals and/or physician payment policy; value-based purchasing legislation (H.R. 1776); other workforce legislation (H.R. 1946, S.1569)); Puerto Rico Medicare Parity (H.R. 2680, H.R. 1501, H.R.1502); Medicare physician payment adjustment (HR. 3961, S.1776, H.R.3326, H.R. 3590, H.R. 4851, S. 3153, H.R. 4213); Section 508 wage index extension and gainsharing extension (H.R. 4213); HIT incentive payment legislation affecting hospitals and physicians in response to proposed rule CMS-0033-P (H.R. 4851, S. 3153, H.R. 4213). Medicaid issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L.111-5) and ARRA FMAP Extension (H.R. 4263, H.R. 2847) provisions related to the Federal Medical Assistance Percentage, provisions related to disproportionate share hospitals, moratoria on Medicaid regulations (CMS-2258-FC,CMS-2279-P, CMS-2213-P, CMS-2275-F, CMS-2287-P), and HIT investments; Medicaid provisions in various health care reform proposals (including the American Health Care Choices Act (Senate HELP Committee bill (S.1679), Affordable Helahtcare for America Act (H.R. 3962), Patient Protection and Affordable Care Act (H.R. 3590), and the Health and Education Reconciliation Act of 2010 (H.R. 4872)), including disproportionate share hospital and FMAP provisions; New York State 1115 Medicaid waiver Partnership Plan extension (11-W-00114/2) provisions related to hospitals; the Medicaid Emergency Psychiatric Care Demonstration Project Act of 2009 (S.1130/H.R.1415); Medicaid incentives for HIV screening (H.R. 3091/S.1446)); HIT incentive payment legislation affecting hospitals and physicians in response to proposed rule CMS-0033-P (H.R. 4851, S. 3153, H.R. 4213).

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239))

FY 2010 Budget Resolutions (H Con Res 312, S Con Res 70) provisions related to Medicare, Medicaid, health reform reserve fund

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); America's Healthy Futures Act (Senate Finance Committee bill); House Tri-Committee bill (H.R. 3200); H.R.3962; H.R.3590); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239))

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788)); Medical malpractice reform issues (in various health care reform proposals (including the American Health Care Choices Act (S. 1679); American Healthy Futures Act of 2009 (Senate Finance Bill); House Tri-Committee bill (H.R. 3200); H.R.3962; H.R.3590); and stand-alone medical malpractice legislation (H.R. 1086; H.R. 3459).

FY 2010 Budget Resolutions (H Con Res 312, S Con Res 70) provisions related to Medicare, Medicaid, health reform reserve fund

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788)); Medical malpractice reform issues (in various health care reform proposals (including the American Health Care Choices Act (S. 1679); American Healthy Futures Act of 2009 (Senate Finance Bill); House Tri-Committee bill (H.R. 3200)); and stand-alone medical malpractice legislation (H.R. 1086; H.R. 3459).

Access to capital for health care institutions under the Federal Housing Act 242 Hospital Mortgage Insurance Program (American Recovery and Reinvestment Act, H.R. 1 (P.L. 111-5))

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788)); Medical malpractice reform issues (in various health care reform proposals (including the American Health Care Choices Act (Senate HELP Committee proposal); Senate Finance Committee delivery system, coverage, and financing options papers; House tri-committee discussion draft bill)

FY 2010 Budget Resolutions (H Con Res 312, S Con Res 70) provisions related to Medicare, Medicaid, health reform reserve fund

Access to capital for health care institutions under the Federal Housing Act Section 242 Hospital Mortgage Insurance Program (American Recovery and Reinvestment Act, H.R. 1 (P.L. 111-5))

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (Senate HELP Committee proposal); Senate Finance Committee delivery system, coverage, and financing options papers; House tri-committee discussion draft bill, later H.R. 3200); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239))

Health Care Reform Issues related to insurance coverage for the uninsured and delivery system and reimbursement reforms in various health care reform proposals (including the American Health Care Choices Act (Senate HELP Committee proposal); Senate Finance Committee delivery system, coverage, and financing options papers; House tri-committee discussion draft bill, later H.R. 3200); health information technology issues (American Recovery and Reinvestment Act of 2009, H.R. 1 (P.L. 111-5)

FY 2010 Budget Resolutions (H Con Res 312, S Con Res 70) provisions related to Medicare, Medicaid, health reform reserve fund

False Claims Act expansion legislation (Fraud Enforcement and Recovery Act of 2009 (S. 386), False Claims Act Clarification Act of 2009 (S. 458/H.R. 1788))

Medicare hospital reimbursement issues and Medicare graduate medical education reimbursement issues (Medicare Improvement for Patients and Providers Act of 2008, H.R.6331, S.3101;CHAMP Act, H.R.3162;Preserving Access to Medicare Act of 2008,S.3118;Inpatient Medicare Prospective Payment System Rule, CMS 1390-P,F;Medicare Recovery Audit Contractor Program Moratorium Act of 2007, H.R.4105;Nursing and Allied Health Education Preservation Act of 2008;H.R.5174;Registered Nurse Safe Staffing Act of 2007, H.R.4138;42CFR413.75,H.R.1093,provisions related to Medicare graduate medical education and the counting of resident work hours, HR 615 & 616 relating to Medicare Parity; PATH Act of 2008 (S.3656, HR 7241) Medicaid reimbursement issues (Iraq War Supplemental Appropriations Bill, H.R. 2642-Provision to Place Moratoria on Medicaid Regulations CMS-2258-FC,CMS 2279-P,CMS 2213-P, and CMS-2275-F; Protecting the Medicaid safety Net Act of 2008, H.R.5613;Public and Teaching Hospital Preservation Act, H.R.3533;Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2007, H.R.2066;Temporary Increase in FMAP (HR5268,S.2586, H.R.7110, S. 3656,S.3689 ) Medicaid Outpatient Regulation (ms 2213-F)

Wired for Healthcare Quality Act (S.1693), provisions related to health information technology. Pro(tech)Act of 2008(H.R.6357), provisions related to health information technology. Health Professional Shortage Area Issues(HRSA)Proposed Rule RIN#0906-AA44).Health Equity and Accountability Act of 2007 (H.R.3014), pertaining to elimination of health care disparities

Registered Nurse safe Staffing Act of 2007 (H.R.4138); Fairness Nursing Home Arbitration (S.2838)

Wired for Healthcare Quality Act (S.1693), provisions related to health information technology.Pro(tech)tAct of 2008(H.R.6357),provisions related to health information technology.Health Professional Shortage Area Issues(HRSA Proposed Rule RIN#0906-AA44). Health Equity and Accountability Act of 2007 (H.R.3014), pertaining to elimination of health care disparities

FY 2009 Budget Resolution (H.Con Res.312.S.Con.Res.70),provisions relating to Medicare and Medicaid cuts; FY 2009 Labor -HHS appropriations (S.3230),provisions related to NIH

Medicare hospital reimbursement issues and Medicare graduate medical education reimbursement issues (Medicare Improvement for Patients and Providers Act of 2008, H.R.6331,S.3101;CHAMP Act,H.R.3162;Preserving Access to Medicare Act of 2008,S.3118;Inpatient Medicare Prospective Payment System Rule,CMS 1390-P;Medicare Recovery Audit Contractor Program Moratorium Act of 2007,H.R.4105;Nursing and Allied Health Education Preservation Act of 2008,H.R.5174;Registered Nurse Safe Staffing Act of 2007,H.R.4138;42 CFR 413.75,provisions related to Medicare graduate medical education and the counting of resident work hours) Medicaid reimbursement issues (Iraq War Supplemental Appropriations Bill,H.R.2642-Provision to Place Moratoria on Medicaid Regulations CMS-2258-FC,CMS 2279-P,CMS 2213-P, and CMS-2275-F;Protecting the Medicaid Safety Net Act of 2008,H.R.5613;Public and Teaching Hospital Preservation Act,H.R.3533;Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2007,H.R.2066)

Registered Nurse Safe Staffing Act of 2007 (H.R.4138);